Assenagon Asset Management S.A. Uro Gen Pharma Ltd. Transaction History

Assenagon Asset Management S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 07, 2020	SELL	$18.81 - $26.42 $170,174 - $239,021	-9,047 Closed	0 $0
Q2 2020 Jul 21, 2020	BUY	$16.5 - $29.7 $149,275 - $268,695	9,047 New	9,047 $236,000
Q3 2019 Oct 16, 2019	SELL	$23.83 - $36.44 $1.39 Million - $2.13 Million	-58,446 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$32.75 - $40.35 $1.33 Million - $1.64 Million	40,704 Added 229.42%	58,446 $2.1 Million
Q1 2019 Apr 26, 2019	BUY	$35.47 - $54.55 $284,930 - $438,200	8,033 Added 82.74%	17,742 $655,000

Q4 2018 Jan 23, 2019	BUY	$38.35 - $50.39 $372,340 - $489,236	9,709 New	9,709 $418,000

113

24M

46.9K

44.3K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $373M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.